, Singapore
291 views
Photo from MAS

MAS issues 12-year ban on former Manulife rep over cheating offences

The rep tricked 25 victims into sending him over $1.2m for a fake investment.

The Monetary Authority of Singapore (MAS) slapped a 12-year prohibition order (PO) against Ong Ka Yong, a former representative of Manulife Financial Advisers, for cheating offences.

The PO, which took effect on 22 April, bars Ong from providing any financial advisory services, participating in the management, serving as a director, or holding a substantial shareholding in any financial advisory firm, as stipulated under the Financial Advisers Act.

In August 2023, Ong was convicted of 11 counts of cheating under section 417 of the Penal Code, with an additional 14 related charges considered during sentencing. The State Court sentenced Ong to 47 months’ imprisonment on 4 September 2023.

MAS reported that between April 2020 and October 2021, Ong deceived 25 victims into transferring over $1.2m to him for fictitious investment opportunities purportedly offered by Manulife and another private company.

RELATED: MAS issues 8-year prohibition orders to ex-Prudential rep 

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.